Abbisko Cayman (STU:8ZD) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Days Payable?

Abbisko Cayman's average Accounts Payable for the six months ended in Jun. 2024 was €0.00 Mil. Abbisko Cayman's Cost of Goods Sold for the six months ended in Jun. 2024 was €0.00 Mil.

The historical rank and industry rank for Abbisko Cayman's Days Payable or its related term are showing as below:

STU:8ZD's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 135.18
* Ranked among companies with meaningful Days Payable only.

Abbisko Cayman's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Abbisko Cayman Days Payable Historical Data

The historical data trend for Abbisko Cayman's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Days Payable Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Abbisko Cayman's Days Payable

For the Biotechnology subindustry, Abbisko Cayman's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbisko Cayman's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's Days Payable distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's Days Payable falls into.

Abbisko Cayman Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Abbisko Cayman's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Abbisko Cayman's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

Abbisko Cayman Days Payable Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

02256:Hong Kong

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman Headlines

No Headlines